How Takeda is thinking about value-based arrangements with payers

July 2, 2021
FierceHealthcare

Related news

In the news

February 20, 2024

FDA Approves Game-Changing Regimen for Urothelial Cancer, but Will Cost Pose Issue?

Reprinted with AIS Health permission from the Feb. 15, 2024, issue of Spotlight…

In the news

January 25, 2024

2023 Notable FDA Approvals Include Several Cell and Gene Therapies, First-Time Biosimilars

Reprinted with AIS Health permission from the January 2024 issue of Radar on…